by Madaline Spencer | Feb 3, 2024
Ponni Subbiah, MD, MPH, Senior Vice President Global Head of Medical Affairs and Chief Medical Officer, Acadia Pharmaceuticals, discusses trofinetide for the treatment of Rett syndrome. Overview of Rett Syndrome Rett syndrome is a neurodevelopmental condition...
by Madaline Spencer and Peter Ciszewski | Jul 27, 2023
Courtney Silverthorn, Ph.D., Associate Vice President for Science Partnerships at the Foundation for the National Institutes of Health (FNIH), discusses the recent announcement that the Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (AMP BGTC) has...
by Madaline Spencer | Jul 26, 2023
Milan Radovich, PhD, Chief Scientific Officer at Caris Life Sciences, discussed the use of artificial intelligence (AI) to improve the diagnosis of different cancer patients. Each patient’s imaging data, electronic health records, exome sequencing data, etc.,...
by Madaline Spencer and Peter Ciszewski | Jul 20, 2023
Rennie McCarthy, Chief Executive Officer at Stealth Biotherapeutics, provides an overview of mitochondrial myopathy, or myopathic mitochondrial DNA depletion syndrome. Mitochondrial myopathy is a rare genetic disorder caused by mutations in nuclear...
by Madaline Spencer and James Radke, PhD | Jul 19, 2023
Karen Ball, founder of the Surge-Weber Foundation discusses Sturge-Weber Syndrome, a rare neurovascular disease. Sturge-Weber syndrome is a rare neurocutaneous disorder that primarily affects the skin and the central nervous system. It is characterized...
